US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

FUNDX FUTURE FUND OPPORTUNITIES ETF

28.16

-0.1090-0.39%

Volume:5K

Turnover:154.60K

Market Cap:227.67M

PE:- -

High:28.16

Open:28.16

Low:28.16

Close:28.27

52wk High:31.30

52wk Low:25.44

Shares:8.09M

Float Shares:8.09M

Volume Ratio:0.75

T/O Rate:0.07%

Dividend:0.50

Dividend Rate:1.76%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

U.S. Stocks on the MOVE-Halozyme Therapeutics, Etsy, Netflix

Halozyme Therapeutics Hits Fresh Record After Increased $1.3 Bln Convertible Bond Sale

Pound and Dollar Gold Prices Reflect Divergent Rate Expectations

Halozyme Prices Upsized USD 1.3 Billion Convertible Senior Notes Offering Due 2033

Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes Due 2033

THOMSON REUTERS

Halozyme Director Matthew L. Posard Disposes of Common Shares Worth USD 2.02 Million

Guardant Health Director Tariq Musa Sells 116 Common Shares for $20,300

US Health Secretary Kennedy Jr. Adds Eight New Members to Key Health Committee

Guardant Health on Track for Record High Close

Japanese Firms Break Ranks to Demand Stronger Yen as Currency Woes Mount

Brazil's Central Bank Trims Rate to 13.75% as Tight Election Race Clouds Future Easing

Halozyme Therapeutics Slips on $1.05 Bln Convertible Offering Plans

Halozyme announces proposed offering of $1.05B of 2033 convertible senior notes

Halozyme Plans USD 1.05 Billion Convertible Senior Notes Offering Due 2033

Halozyme Therapeutics, - Expects to Use Net Proceeds to Repurchase Outstanding 2027 and 2028 Convertible Notes

THOMSON REUTERS

Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes Due 2033

THOMSON REUTERS

FireFox Gold Uncovers New High-Grade Lammas Zone at Mustajärvi Project in Finland

Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says

MT Newswires Live

Guardant Health CIO Kumud Kalia Disposes of 4,000 Common Shares Worth $632,193.20

Guardant Health, - Evicore by Evernorth to Cover Shield Blood Test for Crc Screening Effective Jan 1, 2027

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/FFOX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FFOX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FFOX\",,,,,undefined,":{"symbol":"FFOX","market":"US","secType":"STK","nameCN":"FUNDX FUTURE FUND OPPORTUNITIES ETF","latestPrice":28.16,"timestamp":1789749931251,"preClose":28.269,"halted":0,"volume":5490,"delay":0,"changeRate":-0.0038558137889560373,"floatShares":8085000,"shares":8085000,"eps":0,"marketStatus":"Trading","change":-0.109,"latestTime":"09-18 12:53:37 EDT","open":28.16,"high":28.16,"low":28.16,"amount":154597.82355,"amplitude":0,"askPrice":28.21,"askSize":54,"bidPrice":28.17,"bidSize":3100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789761600000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":28.269,"sharesOutstanding":7155000,"nav":28.12,"aum":227350200,"dividendRate":0.017582,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":28.27,"preClose":28.269,"latestTime":"16:10 EDT","volume":6,"amount":169.614,"timestamp":1789675804068,"change":0.001,"changeRate":0.000035,"amplitude":0},"volumeRatio":0.747432},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FFOX\",,,,,undefined,":{"symbol":"FFOX","floatShares":8085000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.747432,"shares":8085000,"dividePrice":0.4951,"high":28.16,"amplitude":0,"preClose":28.269,"low":28.16,"week52Low":25.44,"pbRate":"--","week52High":31.295,"institutionHeld":0,"latestPrice":28.16,"committee":0.965758,"eps":0,"divideRate":0.017582,"volume":5490,"delay":0,"ttmEps":0,"open":28.16,"prevYearClose":27.27,"prevWeekClose":28.55,"prevMonthClose":29.2799,"prevQuarterClose":30.29,"fiveDayClose":28.55,"twentyDayClose":30.0575,"sixtyDayClose":29.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FFOX\",params:#limit:5,,,undefined,":[{"date":"2025-12-31","symbol":"FFOX","amount":0.49447507,"announcedDate":"2025-12-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-31","defaultRemindTime":1767191400000,"name":"FUNDX FUTURE FUND OPPORTUNITIES ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-02","payableDate":"2025-12-31","currency":"USD","dateTimestamp":1767157200000,"payDate":"2026-01-02"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FFOX\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-31","recordDate":"2025-12-31","paymentDate":"2026-01-02","value":0.49447507,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FFOX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FFOX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668922682","title":"U.S. Stocks on the MOVE-Halozyme Therapeutics, Etsy, Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2668922682","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668922682?lang=en_us&edition=fundamental","pubTime":"2026-09-18 23:52","pubTimestamp":1789746775,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Halozyme Therapeutics, Etsy, NetflixSeptember 18 (Reuters)-Wall Street's main indexes fell on Friday in the final stretch of a turbulent week, as investors assessed shifti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL6N45A0YO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDX","MLPX","SBIO","CRWX","CAVA","DSP","MLPI","TRGP","SGDM","TRUM","AUAU","ETSY","STLD","CORD","AFK","AGMI","PXI","BK4209","CRWG","DT","SLX","CRWU","GLDN","NUE","PYZ","GDMN","CRWV","CWVX","NEM","PICK","UMI","CWII","LU1223082519.USD","XENE","LU0278409577.USD","LU0154245673.USD","FFOX","SLVP","HALO","NEMG","AU","BK4570","TPZ","LU0788108826.HKD","STUB","FMTL","LU2361045086.USD","IBRN","AUMI","NWMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668892177","title":"Halozyme Therapeutics Hits Fresh Record After Increased $1.3 Bln Convertible Bond Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2668892177","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668892177?lang=en_us&edition=fundamental","pubTime":"2026-09-18 22:41","pubTimestamp":1789742496,"startTime":"0","endTime":"0","summary":"BUZZ-Halozyme Therapeutics hits fresh record after increased $1.3 bln convertible bond sale** Shares of Halozyme TherapeuticsHALO.Oup 0.8% at $110.55 and touch fresh record high on Fri after it secure","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nL6N45A0WL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","HALO","BK4139","FFOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127833355","title":"Pound and Dollar Gold Prices Reflect Divergent Rate Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=1127833355","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127833355?lang=en_us&edition=fundamental","pubTime":"2026-09-18 16:20","pubTimestamp":1789719650,"startTime":"0","endTime":"0","summary":"On September 18, gold's performance in different currencies highlighted the growing significance of foreign exchange dynamics. After the Bank of England held its interest rate steady on September 17,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLDM","JAAA","SHNY","EVNT","BK4504","CIK","DZZ","USG","GDXD","CGUI","TAXX","JNUG","NUAG","UGL","DULL","JFLX","GLD","FGLD","NANR","CEF","IBCE","DGZ","IGLD","JDST","GBUG","SLWS","SROI","02840","MFSB","RING","GDXW","DFLV","OUNZ","EVG","BGLD","BUCK","BAR","QMY","GDXY","GLDY","DVVY","GDE","BKLN","KGLD","PALL","VGFPF","DBC","DUST","BEGS","GDXJ","BK4535","BK4588","LQID","FXB","TXXI","GOAU","AAAU","NUGT","KDRN","GDX","PHYS","CMDT","GDXU","THRV","UGLD","YGLD","GBPmain","MGCmain","IAUM","PAYH","SCYB","PYZ","MGBPmain","SGOL","BCFN","DGP","GMOC","FNK","EPU","FITZ","PFLD","GLTR","FNCL","GOLY","BUYO","FFOX","IAU","XLBI","SECR","BK4585","SGDM","BK4207","GLL","FGDL","CERY","SGDJ","IBHJ","BTGD","VSHY","UYM","IAUI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668914384","title":"Halozyme Prices Upsized USD 1.3 Billion Convertible Senior Notes Offering Due 2033","url":"https://stock-news.laohu8.com/highlight/detail?id=2668914384","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668914384?lang=en_us&edition=fundamental","pubTime":"2026-09-18 11:20","pubTimestamp":1789701617,"startTime":"0","endTime":"0","summary":"Halozyme prices upsized USD 1.3 billion convertible senior notes offering due 2033Halozyme priced an upsized private offering of USD 1.3 billion 1.5% convertible senior notes due 2033.Deal increased f","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nNDL7blHh5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HALO","LU0053671581.USD","BK4139","FFOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668826914","title":"Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes Due 2033","url":"https://stock-news.laohu8.com/highlight/detail?id=2668826914","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668826914?lang=en_us&edition=fundamental","pubTime":"2026-09-18 11:20","pubTimestamp":1789701600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260918:nTUAFTWMY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","HALO","FFOX","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668999797","title":"Halozyme Director Matthew L. Posard Disposes of Common Shares Worth USD 2.02 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2668999797","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668999797?lang=en_us&edition=fundamental","pubTime":"2026-09-18 05:20","pubTimestamp":1789680029,"startTime":"0","endTime":"0","summary":"Halozyme director Matthew L. Posard disposes of common shares worth USD 2.02 millionHalozyme director Matthew L. Posard sold 18,996 common shares on Sept. 16, 2026 at prices averaging about $106.13 to","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL71YqMG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Halozyme Director Matthew L. Posard Disposes of Common Shares Worth USD 2.02 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","HALO","BK4139","FFOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668976309","title":"Guardant Health Director Tariq Musa Sells 116 Common Shares for $20,300","url":"https://stock-news.laohu8.com/highlight/detail?id=2668976309","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668976309?lang=en_us&edition=fundamental","pubTime":"2026-09-18 05:10","pubTimestamp":1789679402,"startTime":"0","endTime":"0","summary":"Guardant Health director Tariq Musa sells 116 common shares for $20,300Guardant Health director Tariq Musa sold 116 common shares on Sep. 16, 2026 at USD 175.Directly held common stock fell to 11,449 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nNDL5VHhJ0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Director Tariq Musa Sells 116 Common Shares for $20,300","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH","FFOX","LFSC","BK4196","HELX","BK4585","EKG","GDOC","LU0109394709.USD","PTH","BK4551","LU0889565916.HKD","BK4588","GNOM","BK4535","LU0320765992.SGD","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668995985","title":"US Health Secretary Kennedy Jr. Adds Eight New Members to Key Health Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=2668995985","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668995985?lang=en_us&edition=fundamental","pubTime":"2026-09-17 23:20","pubTimestamp":1789658440,"startTime":"0","endTime":"0","summary":"UPDATE 6-US Health Secretary Kennedy Jr. adds eight new members to key health committeeSept 17 (Reuters)-US Health Secretary Robert F. Kennedy Jr. on Thursday named eight new members to the advisory p","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nL4N4591AI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GH","LU0320765992.SGD","GDOC","FFOX","BK4196","HELX","BK4585","LU0109394709.USD","PTH","LU0889565916.HKD","GNOM","GNMX","BK4588","BK4551","EKG","LFSC","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668998049","title":"Guardant Health on Track for Record High Close","url":"https://stock-news.laohu8.com/highlight/detail?id=2668998049","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668998049?lang=en_us&edition=fundamental","pubTime":"2026-09-17 22:16","pubTimestamp":1789654560,"startTime":"0","endTime":"0","summary":"Guardant Health, Inc.  is currently at $180.24, up $5.34 or 3.05%--Would be new all-time closing high --Would be the first new record closing high since Feb. 12, 2021, when it closed at $179.10--On pace for largest percent increase since Sept. 15, 2026, when it rose 4.65%--Currently up three of the past four days--Up 13.34% month-to-date--Up 76.46% year-to-date--Up 206.52% from 52 weeks ago , when it closed at $58.80--Would be a new 52-week closing high--Up 212.53% from its 52-week closing low of $57.67 on Sept. 24, 2025--Traded as high as $181.50; new all-time intraday high --Up 3.77% at today's intraday highAll data as of 10:14:03 AM ETSource: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Guardant Health on Track for Record High Close","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","HELX","BK4196","GNMX","BK4551","LFSC","GDOC","BK4588","GNOM","BK4535","EKG","LU0320765992.SGD","LU0889565916.HKD","FFOX","PTH","GH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139347293","title":"Japanese Firms Break Ranks to Demand Stronger Yen as Currency Woes Mount","url":"https://stock-news.laohu8.com/highlight/detail?id=1139347293","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139347293?lang=en_us&edition=fundamental","pubTime":"2026-09-17 15:38","pubTimestamp":1789630715,"startTime":"0","endTime":"0","summary":"Corporate leaders across Japan are now pushing for a stronger yen, with even those traditionally benefiting from a weaker currency joining the chorus of concern. Data from the Bank of Japan's July...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXUS","YCS","BAMO","BUFI","HEWJ","KXI","AVDE","TLTI","DUKX","FEOE","AVNM","SHV","ISRVF","NUDM","DFSI","IFEB","JPYmain","AADR","FFOX","FORH","CGIB","VNIE","BLDG","ISRA","BK4585","WBIG","IMAR","IGGY","BK4582","BWZ","PICB","BBIB","ISHP","DIVD","AIRL","TOLL","DIVS","TLT","MOTI","WCMI","PRXI","RWX","SGOV","EBIZ","EQLT","IBCE","DLS","IQLT","PATN","JHID","HFGM","BWX","IJUN","GEOA","EMKT","FEDM","IDVO","PQIN","GMOM","DYNB","GHMS","TINS","JANI","YSEP","ICOW","BBSB","FDRR","SHY","CVIE","WIMA","IAUG","DNL","PPIE","FDTS","BBLB","EUO","ACWI","PIEL","BUFY","RPHS","RSIT","FIVA","TLTX","NTSI","IEF","BBIN","TXXI","EWJ","DSCF","PIEQ","BK4550","IOCT","IFGL","AVSD","DISV","FXY","HEDG","STYL","VIDI","DEEF","TLTW","SEIE","ISCF","IEI","DIM","DUKH","BK4167","IDEC","ISWN","IXUS","TXUE","WIP","TFJL","BKCI","NBIE","ISHG","IDVY","IBUF","IQSI","EMSC","QLVD","JIDE","FLGV","BK4588","TLH","IGOV","GWX","TBJL","EXI","LENS","JPIB","MJYmain","IQDF","YCL","ICPY","TSYW","BGCG","IDV","GXUS","INOV","APLU","GQRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158859379","title":"Brazil's Central Bank Trims Rate to 13.75% as Tight Election Race Clouds Future Easing","url":"https://stock-news.laohu8.com/highlight/detail?id=1158859379","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158859379?lang=en_us&edition=fundamental","pubTime":"2026-09-17 06:00","pubTimestamp":1789596025,"startTime":"0","endTime":"0","summary":"Brazil's central bank cut its benchmark interest rate by 25 basis points on Wednesday, responding to cooling inflation and weakening economic momentum, while a tightly contested presidential race...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["THRV","PFLD","BUYO","FFOX","SLWS","IBCE","JFLX","BUCK","KDRN","NUAG","SROI","TXXI","MFSB","FITZ","SCYB","OTGL","LQID","GMOC","SECR","CGUI","FNK","TAXX","BKLN","EVG","FNCL","EVNT","BCFN","VSHY","QMY","BK4588","DFLV","JAAA","IBHJ","BK4585","CIK","DVVY","PAYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668936889","title":"Halozyme Therapeutics Slips on $1.05 Bln Convertible Offering Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2668936889","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668936889?lang=en_us&edition=fundamental","pubTime":"2026-09-17 05:10","pubTimestamp":1789593054,"startTime":"0","endTime":"0","summary":"BUZZ-Halozyme Therapeutics slips on $1.05 bln convertible offering plans** Shares of Halozyme TherapeuticsHALO.Odown 1.8% at $106.51 in after hours trading as it seeks capital raise** San Diego, Calif","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nL6N458175:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","HALO","FFOX","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668985935","title":"Halozyme announces proposed offering of $1.05B of 2033 convertible senior notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2668985935","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668985935?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:35","pubTimestamp":1789590922,"startTime":"0","endTime":"0","summary":"Halozyme (HALO) Therapeutics “announced that it intends to offer, subject to market conditions and other factors, $1.05 billion aggregate principal...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/halozyme-announces-proposed-offering-of-1-05b-of-2033-convertible-senior-notes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/halozyme-announces-proposed-offering-of-1-05b-of-2033-convertible-senior-notes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0053671581.USD","FFOX","HALO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668895935","title":"Halozyme Plans USD 1.05 Billion Convertible Senior Notes Offering Due 2033","url":"https://stock-news.laohu8.com/highlight/detail?id=2668895935","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668895935?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:31","pubTimestamp":1789590696,"startTime":"0","endTime":"0","summary":"Halozyme plans USD 1.05 billion convertible senior notes offering due 2033Halozyme announced a proposed offering of USD 1.05 billion convertible senior notes due 2033.Deal includes a 13-day option for","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nNDL8s1KsF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FFOX","BK4139","LU0053671581.USD","HALO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668933044","title":"Halozyme Therapeutics, - Expects to Use Net Proceeds to Repurchase Outstanding 2027 and 2028 Convertible Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2668933044","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668933044?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:30","pubTimestamp":1789590601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUA8FSWC6:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FFOX","BK4139","HALO","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668330229","title":"Halozyme Therapeutics, Inc. Announces Proposed Offering of $1.05 Billion of Convertible Senior Notes Due 2033","url":"https://stock-news.laohu8.com/highlight/detail?id=2668330229","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668330229?lang=en_us&edition=fundamental","pubTime":"2026-09-17 04:30","pubTimestamp":1789590601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260916:nTUA8FSWC6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LU0053671581.USD","HALO","FFOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667898849","title":"FireFox Gold Uncovers New High-Grade Lammas Zone at Mustajärvi Project in Finland","url":"https://stock-news.laohu8.com/highlight/detail?id=2667898849","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667898849?lang=en_us&edition=fundamental","pubTime":"2026-09-16 19:56","pubTimestamp":1789559762,"startTime":"0","endTime":"0","summary":"An update from FireFox Gold ( ($TSE:FFOX) ) is now available. FireFox Gold has announced the discovery of the Lammas Zone, a newly recognized high-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/firefox-gold-uncovers-new-high-grade-lammas-zone-at-mustajarvi-project-in-finland?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/firefox-gold-uncovers-new-high-grade-lammas-zone-at-mustajarvi-project-in-finland?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MGCmain","159934","SGUmain","GDX","IAU","NUGT","DUST","518880","GLD","GCmain","SGCmain","FFOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667062145","title":"Guardant Health Could Benefit From AstraZeneca Trial Failure, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2667062145","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667062145?lang=en_us&edition=fundamental","pubTime":"2026-09-16 03:02","pubTimestamp":1789498945,"startTime":"0","endTime":"0","summary":"Guardant Health (GH) stands to benefit from AstraZeneca's (AZN) failed Serena-4 trial because the result preserves the biomarker-driven monitoring approach supporting potential demand for its Guardant","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AZN","HELX","LU2089984988.USD","LU1267930573.SGD","GH","LU0432979614.USD","LU0889565916.HKD","LU0128525929.USD","LU2468319806.SGD","BK4585","LU2237443382.USD","BK4588","LU2237443549.SGD","AZNH","LU0289739699.SGD","LU0058720904.USD","LU2236285917.USD","LU0109394709.USD","PTH","EKG","BK4535","BK4007","FFOX","LU0310800379.SGD","IE00B3T34201.USD","GNOM","LU2456880835.USD","BK4551","LU0320765992.SGD","LU2417539215.USD","BK4568","LU2237443978.SGD","LU2237443465.HKD","LU0029864427.USD","GDOC","LU2237443622.USD","LU2462157665.USD","LU1829250122.USD","BK4196","GNMX","LU0708994859.HKD","LFSC","LU2237443895.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667569983","title":"Guardant Health CIO Kumud Kalia Disposes of 4,000 Common Shares Worth $632,193.20","url":"https://stock-news.laohu8.com/highlight/detail?id=2667569983","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667569983?lang=en_us&edition=fundamental","pubTime":"2026-09-15 06:12","pubTimestamp":1789423938,"startTime":"0","endTime":"0","summary":"Guardant Health CIO Kumud Kalia disposes of 4,000 common shares worth $632,193.20Guardant Health Chief Information Officer Kumud Kalia sold 4,000 common shares on Sept. 11, 2026.The sale price was USD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nNDL3DVtS3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health CIO Kumud Kalia Disposes of 4,000 Common Shares Worth $632,193.20","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","GH","BK4585","LFSC","LU0109394709.USD","FFOX","HELX","GNMX","PTH","GDOC","GNOM","LU0889565916.HKD","LU0320765992.SGD","BK4196","BK4551","EKG","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667087693","title":"Guardant Health, - Evicore by Evernorth to Cover Shield Blood Test for Crc Screening Effective Jan 1, 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2667087693","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667087693?lang=en_us&edition=fundamental","pubTime":"2026-09-15 04:07","pubTimestamp":1789416443,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260914:nFWN4560HZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4535","GDOC","FFOX","GH","GNMX","EKG","GNOM","BK4551","LU0889565916.HKD","HELX","LU0109394709.USD","BK4585","PTH","BK4196","LFSC","LU0320765992.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":101,"code":"91000000","status":"200"}]}}